EDQM grants CEP Certificate for Minoxidil API

Regulatory product approvalBusiness Updates View source PDF Explain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹84.70

prior close

₹85.75

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.4%-0.8% vs market

Pharmaceuticals peers, median of 156sector-2.0%-1.2% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-1.0

15m

-1.0

30m

-2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-2.4-0.8-2.0-1.2

Next day

-2.4-0.4-1.9-1.3-1.1

-3.0-1.1-1.9-1.4-1.6

-0.8-0.6-0.2-1.0+0.2

-2.1-0.4-1.7-0.8-1.3

-2.3+0.1-2.4-0.5-1.8

-5.1-1.4-3.7-2.1-3.0

15d

-5.0-1.0-4.0-2.0-3.0

-5.8-0.8-5.1-0.8-5.1

-7.1-0.9-6.1-5.0-2.1

-15.1-11.3-3.8-10.8-4.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

EDQM has granted a Certificate of Suitability (CEP) to IOL Chemicals and Pharmaceuticals for its API product Minoxidil on 4th December 2025. Minoxidil is mainly used as a topical treatment for hereditary hair loss. The CEP allows the company to supply this API in the European market.

Likely market impact

Positive — opens European market access for Minoxidil API, supporting export revenue growth and product portfolio expansion.